MannKind Corp
MNKD
#4991
Rank
A$2.53 B
Marketcap
A$8.27
Share price
2.66%
Change (1 day)
-15.53%
Change (1 year)

MannKind Corp (MNKD) - P/B ratio

P/B ratio as of January 2026 : -39.9

According to MannKind Corp's latest financial reports the company has a price-to-book ratio of 5.66606.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

MannKind Corp - P/B ratio (from 2004 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31-38.661.74%
2024-12-31-23.9498.66%
2023-12-31-3.99-28%
2022-12-31-5.545.56%
2021-12-31-5.2428.28%
2020-12-31-4.09185.12%
2019-12-31-1.4326.64%
2018-12-31-1.13-11.83%
2017-12-31-1.28-22.59%
2016-12-31-1.66-6.5%
2015-12-31-1.77-93.82%
2014-12-31-28.7-54.1%
2013-12-31-62.5947.62%
2012-12-31-5.97470.27%
2011-12-31-1.05-81.14%
2010-12-31-5.55-66.79%
2009-12-31-16.7-514.44%
2008-12-314.0382.01%
2007-12-312.22-29.74%
2006-12-313.1579.01%
2005-12-311.76-48.06%
2004-12-313.39

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.59-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
9.87-124.73%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
38.5-196.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.21-113.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
17.1-142.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
8.42-121.11%๐Ÿ‡บ๐Ÿ‡ธ USA